Biomarkers to advance drug development for Alzheimer’s disease

By Schulman Howard  

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 409-415

Future Medicine

Access to resources Recommend Favorite

Impaired Renal Function and Biomarkers of Vascular Disease in Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 3, 2014-03 ,pp. : 253-258

Bentham Science Publishers

Access to resources Recommend Favorite

F₂-Isoprostanes as Biomarkers of Late-onset Alzheimer’s Disease

By Montine Thomas   Quinn Joseph   Kaye Jeffrey   Morrow Jason  

Journal of Molecular Neuroscience, Vol. 33, Iss. 1, 2007-09 ,pp. : 114-119

Humana Press, Inc

Access to resources Recommend Favorite

Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

By Hu William   Chen-Plotkin Alice   Arnold Steven   Grossman Murray   Clark Christopher   Shaw Leslie   Pickering Eve   Kuhn Max   Chen Yu   McCluskey Leo   Elman Lauren   Karlawish Jason   Hurtig Howard   Siderowf Andrew   Lee Virginia   Soares Holly   Trojanowski John  

Acta Neuropathologica, Vol. 119, Iss. 6, 2010-06 ,pp. : 669-678

Springer Publishing Company

Access to resources Recommend Favorite

Tuberin – A New Molecular Target in Alzheimer’s Disease?

By Ferrando-Miguel Rosa   Rosner Margit   Freilinger Angelika   Lubec Gert   Hengstschläger Markus  

Neurochemical Research, Vol. 30, Iss. 11, 2005-11 ,pp. : 1413-1419

Springer Publishing Company

Access to resources Recommend Favorite